Medicine Grand Rounds EM FY2020 - COVID-19 Coagulopathy: Diagnosis, Interventions and Thrombosis Prevention (4/17/20)
Starts On:
Mon, 4/20, 2020: 12:00 AM
Ends On:
Thu, 6/30, 2022: 12:00 AM
Type:
Enduring Material
Credits:
1
Description:
ESTIMATED TIME TO COMPLETE: 1 hour
Date of Review: 4/20/20
Termination Date: 6/30/22
ACCREDITATION INFORMATION
In support of improving patient care, The Robert Larner College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Vermont designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ADDITIONAL RESOURCES:
Contacts:
Kramer Wahlberg, MD
kramer.wahlberg@uvmhealth.org
Date of Review: 4/20/20
Termination Date: 6/30/22
ACCREDITATION INFORMATION
In support of improving patient care, The Robert Larner College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Vermont designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ADDITIONAL RESOURCES:
Contacts:
Kramer Wahlberg, MD
kramer.wahlberg@uvmhealth.org
Objectives:
1. Define the pathophysiology and diagnosis of Sepsis Induced Coagulopathy and DIC
2. Review the current data in regards of COVID-19 infection and coagulopathy
3. Learn about available treatments for Sepsis Induced Coagulopathy and DIC
4. Discuss the approach to thrombosis prevention in these patients.
2. Review the current data in regards of COVID-19 infection and coagulopathy
3. Learn about available treatments for Sepsis Induced Coagulopathy and DIC
4. Discuss the approach to thrombosis prevention in these patients.
Disclosure Information:
The planners, speaker and CMIE staff have no financial disclosures. This activity did not receive any commercial support.
Speaker(s)
Mansour Gergi, MD, Universtiy of Vermont Medical Center - View DisclosureDr. MARY CUSHMAN, MD, MSc, University of Vermont - View Disclosure
Topic Categories:
Medicine
